Dean Eliott, MD

Dr. Eliott is a full time retina surgeon, scientist, and Associate Director of the Mass. Eye and Ear Retina Service. He enjoys a national reputation as a gifted vitreo-retinal surgeon and is sought by colleagues for difficult surgical cases. He is also active in clinical trials for retinal disease and possesses a strong interest in translational research on diabetic retinopathy, AMD and non-diabetic retinal vascular disease. 

Dr. Eliott attended Duke University as an undergraduate, moving on to Vanderbilt University School of Medicine. He then completed his Ophthalmology residency at Wilmer/Johns Hopkins Hospital where he served as chief resident, followed by a vitreoretinal fellowship at Duke and six years on the faculty at Kresge Eye Institute in Detroit.  Before coming to Mass. Eye and Ear, Dr. Eliott was Professor of Ophthalmology, Director of Clinical Affairs and Director of Vitreoretinal Fellowship at the USC Keck School of Medicine’s Doheny Eye Institute in Los Angeles. He has been awarded membership in Alpha Omega Alpha, a Heed fellowship, an AAO 2004 Achievement Award, and the Vitreous Society’s 2003 Honor Award.  Read the announcement about Dr. Eliott's appointment here.

Research and Clinical Interests

Diabetic retinopathy, macular degeneration, retinal detachment, surgery for retina-vitreous disorders and ocular trauma

Publications

For a full publication list, please see his CV. A representative list (2006 - 2012) is available through www.pubmed.gov.

VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group, Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Patel M. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology. 2006 Sep; 113 (9):1508.e1-25.

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5; 355(14): 1419-31.

Memarzadeh F, Varma R, Lin LT, Parikh JG, Dustin L, Alcaraz A, Eliott D. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci. 2009 Jul; 50(7): 3233-7.

Kaiser RS, Prenner J, Scott IU, Brucker AJ, Flynn HW Jr, Williams GA, Ho AC, Regillo CD, Capone A, Avery R, Eliott D, Dugel P, Pollack J. The Microsurgical Safety Task Force: evolving guidelines for minimizing the risk of endophthalmitis associated with microincisional vitrectomy surgery. Retina. 2010 Apr; 30(4): 692-9.

Gentile RC, Eliott D. Silicone oil retention sutures in aphakic eyes with iris loss. Arch Ophthalmol. 2010 Dec; 128(12): 1596-9.

Page updated: April 30, 2013